No active exclusion found for this UEI, CAGE or legal name.
| Registration | Active / All awards / expires 2027-06-05 |
|---|---|
| Legal name | PERFUSION MEDICAL, INC. |
| Address | 3002 HUGHSMITH CT, HERNDON, VA, 20171, USA / district 11 |
| Structure | Corporate entity (not tax exempt), incorporated in DE / in business since 2020-03-03 |
| NAICS | 325412 (+2 more) |
| API | registration JSON / SAM.gov record |
| Contract ID | Obligated (FY24+) | Type | Agency | Category | Description | Latest Action |
|---|---|---|---|---|---|---|
| FA864924P0531 | $1.8M | purchase order | Department of the Air Force | Defense systems R&D | Human clinical trial for safety of pm-208 anti-shock drug | Sep 25, 2025 |
| FA864924P0552 | $1.8M | purchase order | Department of the Air Force | Defense systems R&D | Research and development of optimal dosing and formulation of pm-208 (peg-20k/8k) for af field use | Nov 18, 2025 |
| HT942726CE025 | $1.5M | definitive contract | Defense Health Agency | Health R&D | Ind-enabling studies of pm-208: a novel pre-hospital anti-shock therapeutic | Apr 3, 2026 |
| FA864924P0833 | $110K | purchase order | Department of the Air Force | Defense systems R&D | Polyethylene glycol-20k/8k (peg-20k/8k): a patented intravenous solution in uncontrolled hemorrhage | May 13, 2024 |
| FA864924P0274 | $75K | purchase order | Department of the Air Force | Defense systems R&D | Polyethylene glycol-20k/8k: a patented intravenous solution to acute kidney injury | Dec 11, 2023 |
| HT942523C0065 | $0 | definitive contract | Defense Health Agency | Health R&D | Dha sbir direct to phase ii medical R&D contract from proposal no. h2d-0122 for "ind-enabling studies of pm-208: a novel pre-hospital anti-shock therapeutic" | Jul 29, 2025 |
Unused ceiling is uncommitted capacity across available contract records, not guaranteed spending. Vehicle details summarize the largest 500 records.
| # | Agency | Awards | Obligated | Share |
|---|---|---|---|---|
| 1 | Department of the Air Force | 4 | $3.8M | 72% |
| 2 | Defense Health Agency | 2 | $1.5M | 28% |
| # | Category | Awards | Obligated | Share |
|---|---|---|---|---|
| 1 | Defense systems R&D | 4 | $3.8M | 72% |
| 2 | Health R&D | 2 | $1.5M | 28% |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 24, 2026.
Export Custom Datasets or Query the AwardTape API
Select from 6 core datasets (Contractors, Contract Instruments, Expiring Recompetes, Allied Procurement, HV Grid Queue, Sanctions/UFLPA), filter by company, ticker, or PIID, and export in CSV, JSON, or Markdown Brief.
Building an AI agent? Get this company profile as JSON: GET /api/agent/v1/companies/perfusion-medical. Schema, sample and price or start with free sample calls.